About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PRotEin Provision in Critical IllneSs -2 | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNANCT07529522

PRotEin Provision in Critical IllneSs -2

When patients survive a life-threatening condition in the intensive care unit (ICU), they often face a prolonged recovery process marked by persistent health issues that significantly reduce their qua...

Lead sponsor: Ziekenhuis Oost-Limburg•15 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Ziekenhuis Oost-Limburg

Collaborators

Federaal Kenniscentrum voor Gezondheidszorg, Belgium

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult (≥ 18 years-old) patient
•Admission to the ICU
•Invasive, mechanical ventilation initiated within 72 hours following ICU admission, or mechanically ventilated upon arrival to the ICU
•Expected ICU stay on mechanical ventilation of ≥ 3 days after randomisation

Exclusion Criteria

•Expected contra-indication for enteral nutrition for at least one week, at the discretion of the treating physician, such as a bowel discontinuity that cannot be solved within one week
•Moribund (expected to die within 48 hours) or withholding of treatment (DNR code 3)
•Previous inclusion in the PRECISe-2 trial
•Transfer from another ICU with an ICU stay longer than 3 days

Related studies

Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients

NCT05993390 · Neuromuscular Blockade, Critical Illness, and more

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

NCT05218083 · COVID-19, Critical Illness, and more

NIBP Validation Study

NCT05673408 · Critical Illness

Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial

NCT07183592 · Intensive Care (ICU), Central Venous Catheter Related Infections, and more

CALLY Index, Frailty and SOFA-2 for Mortality Prediction in Geriatric ICU Patients

NCT07579728 · Critical Illness, Frailty, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 23, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment1,026

Start dateMay 2026

Last updatedApr 23, 2026

Condition

Critical Illness Intensive Care (ICU)

Locations shown

UZ Antwerpen

Antwerp

Ziekenhuis Oost-Limburg

Genk

AZ Maria Middelares

Ghent

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 23, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions